Delivery Order SPE2DB22D3016-SPE2DB25FBJJ0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100 count) with a ceiling value of $1,990.20. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is scheduled for completion by September 15, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,245.55 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract type. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,648.34. This competitively awarded, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count) with a ceiling value of $1,104.99 under a firm fixed-price contract type. The award, issued on May 1, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of May 2, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,997.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a $1,917.24 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,670.98. This firm fixed-price delivery order, which is due for completion by September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $1,149.20. This non-set-aside award is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJJ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,680.33. This competitively awarded, firm fixed price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a continuation of the vendor's established pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains. The vendor's track record with DLA demonstrates consistent capability to fulfill federal medical supply requirements through open competition, positioning it as a primary source for controlled substances and other critical pharmaceuticals needed by defense health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/15/25 |